Leica Biosystems Unites Pharma, Pathologists, and Oncologists to Help Shape the Future of Digital Pathology and Enable More Precise Patient Therapies

[DEER PARK, Ill. — June 9, 2026] — Leica Biosystems, a Danaher company and a global leader in end to end anatomic and digital pathology solutions, is advancing how pharmaceutical organizations scale digital and computational pathology to...

OSLO, Norway, June 8, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, and Artera, a leading precision medicine company, announce launch of a joint research initiative. The collaboration encompasses Photocure's...

Collaboration will apply Aignostics AI-technology to PanCAN's multimodal pancreatic cancer dataset, with results made broadly accessible to both academic and life sciences researchers. LOS ANGELES and BERLIN and NEW YORK, June 9,...

Discover commonly used tools to get started today with RNAscope™ image analysis in HALO® From Images to Insights: Getting Started with RNAscope™ Image Analysis in HALO® In collaboration with Bio-Techne...

MT Group: 23-year-old biospecimen CRO marks milestone with expanded capabilities for translational research, biomarker discovery, companion diagnostic development, and liquid biopsy validation across oncology and autoimmune programs LOS...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, Yale New Haven Hospital (YNHH) and Memorial Sloan Kettering Cancer Center (MSK) today announced the...